South Korea, DIA Explore Collaboration for Training
Korea National Enterprise for Clinical Trials (KoNECT) and DIA (Drug Information Association) have signed a Memorandum of Understanding to establish a cooperative relationship and explore collaboration in development of training, education and knowledge exchange opportunities.
Korea National Enterprise for Clinical Trials (KoNECT) and the DIA have signed a Memorandum of Understanding to establish a cooperative relationship and explore collaboration in development of training, education and knowledge exchange opportunities. Both organizations have an interest in delivering educational offerings through classroom and on-line training courses along with additional opportunities to further develop and advance innovations in therapeutic product development.
KoNECT was established in April, 2014 as a non-profit foundation by the Korean Ministry of Health and Welfare for the purpose of furthering development of clinical trial infrastructure and capability, with an objective to establish Korea as a global clinical trial hub and preferred partner for drug development in the Asia Pacific region, as the continuum of the 1st KoNECT established in December 2007.
Additional information is in this release.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
